Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli

Stina Söderlund,Lisa Christiansson,Inger Persson,Henrik Hjorth-Hansen,Johan Richter,Bengt Simonsson,Satu Mustjoki,Ulla Olsson-Strömberg,Angelica Loskog

Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli

2016

Stina Söderlund
Lisa Christiansson
Inger Persson
Henrik Hjorth-Hansen
Johan Richter
Bengt Simonsson
Satu Mustjoki
Ulla Olsson-Strömberg
Angelica Loskog

BACKGROUND AND AIMS: The simultaneous measurement of many proteins is now possible using multiplex assays. In this pilot study we investigated a total of 124 proteins in plasma from chronic myeloid ...

Keywords:

Immunity
Cancer research
Bone marrow
Immunology
Chronic myelogenous leukemia
Angiogenesis
Myeloid
Tyrosine-kinase inhibitor
Biology
Imatinib
Proteomics
Hematology
Stem cell
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations